CN103417879A - 一种治疗牛皮癣的药物 - Google Patents
一种治疗牛皮癣的药物 Download PDFInfo
- Publication number
- CN103417879A CN103417879A CN2013103663420A CN201310366342A CN103417879A CN 103417879 A CN103417879 A CN 103417879A CN 2013103663420 A CN2013103663420 A CN 2013103663420A CN 201310366342 A CN201310366342 A CN 201310366342A CN 103417879 A CN103417879 A CN 103417879A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- treatment
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 229940079593 drug Drugs 0.000 title claims abstract description 12
- 201000004681 Psoriasis Diseases 0.000 title abstract description 19
- 239000000463 material Substances 0.000 claims abstract 2
- 241000628997 Flos Species 0.000 claims description 16
- 241000255791 Bombyx Species 0.000 claims description 8
- 241000903946 Clematidis Species 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 206010043866 Tinea capitis Diseases 0.000 claims description 8
- 208000009189 tinea favosa Diseases 0.000 claims description 8
- 230000002682 anti-psoriatic effect Effects 0.000 claims description 5
- 229940030999 antipsoriatics Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 10
- 238000002156 mixing Methods 0.000 abstract description 6
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 241000555682 Forsythia x intermedia Species 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000212948 Cnidium Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 241000270273 Ptyas dhumnades Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000299492 Thespesia populnea Species 0.000 abstract 1
- 235000009430 Thespesia populnea Nutrition 0.000 abstract 1
- 206010040882 skin lesion Diseases 0.000 description 12
- 231100000444 skin lesion Toxicity 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 208000003251 Pruritus Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000002085 persistent effect Effects 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010037888 Rash pustular Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 208000029561 pustule Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 208000005775 Parakeratosis Diseases 0.000 description 3
- 206010037575 Pustular psoriasis Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000003448 neutrophilic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 240000005498 Setaria italica Species 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 210000003701 histiocyte Anatomy 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000002252 panizo Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000001185 psoriatic effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 206010000349 Acanthosis Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000008822 Ankylosis Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012455 Dermatitis exfoliative Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015278 Erythrodermic psoriasis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023198 Joint ankylosis Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000003076 Osteolysis Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000005267 amalgamation Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- -1 clean Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 208000023368 generalized pustular psoriasis Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 244000309465 heifer Species 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000029791 lytic metastatic bone lesion Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种疗效快、疗程短、不易复发的治疗牛皮癣的药物,是由以下重量份数的中药为原料药制备获得的:白癣皮12-18、土茯苓28-32、苦参12-18、黄柏10-20、地肤子25-35、蛇床子25-35、金银花25-35、青连翘10-18、蒲公英25-35、野菊花25-35、生地25-35、苍术12-18、白花蛇舌草15-25、生地榆15-25、何首乌25-35、防风12-18、羌活12-18、僵蚕5-15、蝉蜕8-12、威灵仙12-18、穿山甲8-12、皂角刺10-20、乌梢蛇10-20,将上述各种原料药物按重量份数混合均匀,粉碎成100目的细粉,消菌制成散剂。
Description
技术领域
本发明属于中药制剂的技术领域,具体的说是一种治疗牛皮癣的药物。
背景技术
牛皮癣作为一种常见的慢性皮肤病,其特征是在红斑上反复出现多层银白色干燥鳞屑。中医古称之为“白疕”,古医籍亦有称之为松皮癣。西医称为银屑(Psoriasis),俗称牛皮癣。牛皮癣顽固难治,仍被列为当今世界皮肤科领域的重要研究课题,是全世界皮肤科重点防治疾病之一。由于西医治疗银屑病主要是消除症状,避免进一步恶化,无法根治,且副作用较大,所以在近年来召开的全国银屑病防治协作会议上,与会专家一致认为“西医抗癌药和激素类药物有严重的副作用,应尽量避免使用”。
发明内容
本发明的目的是解决西医治疗牛皮癣副作用较大而提供了一种疗效快、疗程短、不易复发的治疗牛皮癣的药物。
本发明的药物是由以下重量份数的中药为原料药制备获得的:
白癣皮12-18 土茯苓28-32 苦参12-18
黄柏10-20 地肤子25-35 蛇床子25-35
金银花25-35 青连翘10-18 蒲公英25-35
野菊花25-35 生地25-35 苍术12-18
白花蛇舌草15-25 生地榆15-25 何首乌25-35
防风12-18 羌活12-18 僵蚕5-15
蝉蜕8-12 威灵仙12-18 穿山甲8-12
皂角刺10-20 乌梢蛇10-20。
所述各原料药的优选重量份数为:
白癣皮15 土茯苓30 苦参15
黄柏15 地肤子30 蛇床子30
金银花30 青连翘15 蒲公英30
野菊花30 生地30 苍术15
白花蛇舌草20 生地榆20 何首乌30
防风15 羌活15 僵蚕10
蝉蜕10 威灵仙15 穿山甲10
皂角刺15 乌梢蛇15。
上述各组份的药物可以制成散剂或水煎服。本发明优选的剂型是散剂。
将上述各原料药除去杂质,洗净,按照所述重量份数混合,粉碎成细粉,消毒后制成散剂,装袋,每袋15 克。
本发明组方中,白癣皮具有清热燥湿,祛风解毒的功能,用于湿热疮毒,黄水淋漓,湿疹,风疹,疥癣疮瘌,风湿热痹,黄疸尿赤;土茯苓解毒,除湿,利关节,主治治梅毒,淋浊,筋骨挛痛,脚气,疗疔疮,痈肿,瘰疬, 梅毒及汞中毒所致的肢体拘挛,筋骨疼痛;苦参清热解毒、抗菌消炎,主治湿热燥湿、黄疸、赤白带下、阴痒、麻风;黄柏泻火解毒,除骨蒸清虚热,用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒;地肤子清热利湿,祛风止痒;用于小便涩痛、阴痒带下、风疹、湿疹、皮肤瘙痒;蛇床子解毒杀虫 燥湿祛风;金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效;青连翘有抗菌、强心、利尿、镇吐等药理作用,常用连翘治疗急性风热感冒、痈肿疮毒、淋巴结结核、尿路感染等症;蒲公英具有清热解毒、利尿散结的功效;野菊花含可广泛用于治疗疔疮痈肿、咽喉肿痛、风火赤眼、头痛眩晕等病证,同时又有很好的降压作用,可用于高血压病的辅助治疗;生地清热、生津、润燥、滑肠、破瘀、生新、止痛、调经、金疮瘀、凉血、止血、活血;苍术用于湿阻脾胃、脘腹胀满,寒湿白带,湿温病以及湿热下注、脚膝肿痛、痿软无力;白花蛇舌草清热解毒,消痈散结,利水消肿,用于咽喉肿痛,肺热喘咳,热淋涩痛,湿热黄疸,毒蛇咬伤,疮肿热痈;生地榆除下焦热,治大小便血证;何首乌解毒,消痈,润肠通便,用于瘰疠疮痈,风疹瘙痒,肠燥便秘;防风祛风解表、胜湿止痛、解痉、止痒;羌活解表散寒,祛风胜湿,止痛;僵蚕祛风定惊,化痰散结;蝉蜕宣散风热、透疹利咽、退翳明目、祛风止痉;威灵仙祛风除湿,通络止痛,消痰水,散癖积;穿山甲活血散结,通经下乳;皂角刺用于疮疹顽癣,产后缺乳,胎衣不下,疠风;乌梢蛇祛风,通络,止痉。
为进一步考察本发明药物治疗牛皮癣的临床疗效,选择50 例牛皮癣患者进行了临床疗效观察。
临床资料:
选择门诊病人50 例,其中男28例、女22 例,病程1~12年,年龄15~65 岁。全部病例均根据《中医病症诊断疗效标准》中牛皮癣的诊断标准,确诊为牛皮癣。
诊断标准
(一) 寻常型银屑病
1. 通常好发于头皮、四肢伸侧,腰背部 ,严重泛发全身;
2. 皮损通常为红色斑疹、斑片、斑块和丘疹,绿豆至钱币大小,可相互融合,表面覆多层银白色鳞屑,去除鳞屑可有薄膜现象和点状出血现象(又称血露现象),在疾病的进展期,可出现同行反应,皮损轻中程度的瘙痒;
3. 指趾甲受累可出现甲凹点,纵嵴等。真菌学检查阴性;
4. 黏膜受累较甲板少见。常见于**和包皮内侧,为境界清楚的暗红斑,表面鳞屑不多。口腔黏膜及舌黏膜亦可受累,表现为白色斑片,周围有红晕;
5. 头皮累及时,头发呈束状,是其特征。一般无头发脱落;
6. 大部分患者病情冬季加重,夏季好转或缓解;
7. 部分患者有家族史;
8. 根据病情活动情况,将银屑病分为进行期、静止期和消退期。进行期表现为皮损进行性加重,新皮损不断出现,原有皮损进行性扩大,薄膜现象和血露现象典型;静止期皮损既不加重,也不消退;消退期时皮损鳞屑减少,皮损变薄、缩小变淡,最终完全消退。组织病理表现: 寻常型银屑病的组织病理表现具有特征性。主要表现为融合性角化不全,角化不全中可见Munro小脓疡,颗粒层变薄或消失,表皮突规则延长,真皮RT上延,小血管迂曲、扩张、充血,真皮浅层小血管周围灶状淋巴细胞为炎性细胞主浸润。
(二) 脓疱型银屑病
临床上根据皮损部位和面积分为局限型和系统型。
(1)局限性脓疱型银屑病
1. 好发于掌跖部位;
2. 通常皮损对称分布,少数亦可不对称;
3. 皮损表现为周期性发生的红斑基础上的扁平的粟粒大角质层下无菌性脓疱,一般1-2月脓疱可自行干涸脱屑。
(2)泛发性脓疱型银屑病
1. 可有或无寻常型银屑病病史;
2.全身皮肤弥漫性红斑基础上出现密集黄白色浅表无菌性脓疱,针帽至粟粒大小,可互融合成脓湖;
3.通常可伴高热,并且皮损发生与发热相平行;
4.病情呈周期性反复发作。 组织病理表现:基本与寻常型银屑病相同。但于棘层上部出现海绵状脓疱,疱内主要为中性粒细胞。真皮层炎症浸润较重,主要为淋巴细胞和组织细胞,有少量中性粒细胞。
(三) 关节病型银屑病
1. 有寻常型银屑病或其它类型银屑病病史;
2. 通常累及手足部小关节,病变关节数量少并且不对称,严重可累及全身多个大小关节,并可造成关节残毁;
3. X线示,病变关节侵蚀,骨质溶解,关节间隙变窄,关节强直,骨膜性新骨形成,关节内及关节周围积液;
4. 排除其它原因引起的关节病变。实验室检查血沉增快,类风湿因子、血尿酸及ANA抗体为阴性,B27抗原检测常为阳性。
(四) 红皮病型银屑病
1. 有寻常型银屑病病史;
2. 发病前常有突然停止外用强效糖皮质激素,或停止系统应用糖皮质激素或MTX等药物,或同时合并其它系统疾病感染,或外用具有较强刺激性的药物;
3. 全身皮肤弥漫性潮红浸润,肿胀及脱屑,有时见小片正常皮肤;
4. 排除其它原因如药物、肿瘤等引起的红皮病。 组织病理表现:除银屑病的病理特征外,其变化与慢性皮炎相似。呈显著角化不全,颗粒层变薄或消失,棘层肥厚,表皮嵴延长,有明显的细胞内和细胞间水肿,但不形成水疱。真皮上部水肿,血管扩张充血,血管周围早期有中性粒细胞和淋巴细胞浸润,晚期多为淋巴细胞、组织细胞及浆细胞等。
治疗方法:
口服本发明药物,每日三次,每次一袋,每袋15克,空肚子水冲服。十剂为一个疗程,一般3-4个疗程,全身退净,顽疾得除,再不复发。 疗效标准
显效:皮疹消退70%以上,主觉瘙痒症状消失。
好转;经治疗后皮疹消退不足30%,主觉症状减轻。
无效:治疗前后无变化,或见新疹发出。
治疗结果:
50 例患者经口服本发明药物治疗4个疗程,治愈45例、好转3例、无效2例,治愈率90%,有效率96%,服药期间,无不良反应。
具体实施方式
实施例1
称取除去杂质,清洗干净的白癣皮15g、土茯苓30g、苦参15g、黄柏15g、地肤子30g、蛇床子30g、金银花30g、青连翘15g、蒲公英30g、野菊花30g、生地30g、苍术15g、白花蛇舌草20g、生地榆20g、何首乌30g、防风15g、羌活15g、僵蚕10g、蝉蜕10g、威灵仙15g、穿山甲10 g、皂角刺15g、乌梢蛇15g混合均匀,粉碎成100目的细粉,消菌后制成散剂,装袋,每袋15克。
口服本发明药物,每日三次,每次一袋,每袋15克,空肚子水冲服。十剂为一个疗程,一般3-4个疗程,全身退净,顽疾得除,再不复发。
实施例2
称取除去杂质,清洗干净的白癣皮12g、土茯苓28g、苦参12g、黄柏10g、地肤子25g、蛇床子25g、金银花25g、青连翘10g、蒲公英25g、野菊花25g、生地25g、苍术12g、白花蛇舌草15g、生地榆15g、何首乌25g、防风12g、羌活12g、僵蚕5g、蝉蜕5g、威灵仙12g、穿山甲8g、皂角刺10g、乌梢蛇10g混合均匀,粉碎成100目的细粉,消菌后制成散剂,装袋,每袋15克。
口服本发明药物,每日三次,每次一袋,每袋15克,空肚子水冲服。十剂为一个疗程,一般3-4个疗程,全身退净,顽疾得除,再不复发。
口服本发明药物,每日三次,每次一袋,每袋15克,空肚子水冲服。十剂为一个疗程,一般3-4个疗程,全身退净,顽疾得除,再不复发。
实施例3
称取除去杂质,清洗干净的白癣皮18g、土茯苓32g、苦参18g、黄柏20g、地肤子35g、蛇床子35g、金银花35g、青连翘18g、蒲公英35g、野菊花35g、生地35g、苍术18g、白花蛇舌草25g、生地榆25g、何首乌35g、防风18g、羌活18g、僵蚕15g、蝉蜕12g、威灵仙18g、穿山甲12g、皂角刺20g、乌梢蛇20g混合均匀,粉碎成100目的细粉,消菌后制成散剂,装袋,每袋15克。
口服本发明药物,每日三次,每次一袋,每袋15克,空肚子水冲服。十剂为一个疗程,一般3-4个疗程,全身退净,顽疾得除,再不复发。
Claims (2)
1.一种治疗牛皮癣的药物,由以下重量份数的中药为原料药制备获得的:
白癣皮12-18 土茯苓28-32 苦参12-18
黄柏10-20 地肤子25-35 蛇床子25-35
金银花25-35 青连翘10-18 蒲公英25-35
野菊花25-35 生地25-35 苍术12-18
白花蛇舌草15-25 生地榆15-25 何首乌25-35
防风12-18 羌活12-18 僵蚕5-15
蝉蜕8-12 威灵仙12-18 穿山甲8-12
皂角刺10-20 乌梢蛇10-20。
2.根据权利要求1所述的治疗牛皮癣的药物,其中各原料药物的重量份数为:
白癣皮15 土茯苓30 苦参15
黄柏15 地肤子30 蛇床子30
金银花30 青连翘15 蒲公英30
野菊花30 生地30 苍术15
白花蛇舌草20 生地榆20 何首乌30
防风15 羌活15 僵蚕10
蝉蜕10 威灵仙15 穿山甲10
皂角刺15 乌梢蛇15。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310366342.0A CN103417879B (zh) | 2013-08-21 | 2013-08-21 | 一种治疗牛皮癣的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310366342.0A CN103417879B (zh) | 2013-08-21 | 2013-08-21 | 一种治疗牛皮癣的药物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103417879A true CN103417879A (zh) | 2013-12-04 |
| CN103417879B CN103417879B (zh) | 2015-09-30 |
Family
ID=49643619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310366342.0A Expired - Fee Related CN103417879B (zh) | 2013-08-21 | 2013-08-21 | 一种治疗牛皮癣的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103417879B (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104224994A (zh) * | 2014-09-05 | 2014-12-24 | 陆江涛 | 一种祛风除湿的中药组合物及其制备方法 |
| CN105194469A (zh) * | 2015-11-11 | 2015-12-30 | 尹柱良 | 一种治疗银屑病的中药口服液及制备方法 |
| CN106215047A (zh) * | 2016-08-18 | 2016-12-14 | 初立国 | 一种治疗牛皮癣皮炎湿疹的药物及其制备方法 |
| CN113521141A (zh) * | 2020-04-17 | 2021-10-22 | 菏泽市牡丹区令中劳务有限公司 | 一种治疗牛皮癣用涂抹药膏 |
| JP2023503844A (ja) * | 2019-11-19 | 2023-02-01 | 天士力医薬集団股分有限公司 | 乾癬を治療する漢方薬組成物、その製造方法及び使用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1589849A (zh) * | 2003-08-29 | 2005-03-09 | 万荣宏 | 一种治疗牛皮癣的方法 |
| CN102688420A (zh) * | 2012-03-28 | 2012-09-26 | 卢爱萍 | 一种治疗牛皮癣的中药汤剂 |
-
2013
- 2013-08-21 CN CN201310366342.0A patent/CN103417879B/zh not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1589849A (zh) * | 2003-08-29 | 2005-03-09 | 万荣宏 | 一种治疗牛皮癣的方法 |
| CN102688420A (zh) * | 2012-03-28 | 2012-09-26 | 卢爱萍 | 一种治疗牛皮癣的中药汤剂 |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104224994A (zh) * | 2014-09-05 | 2014-12-24 | 陆江涛 | 一种祛风除湿的中药组合物及其制备方法 |
| CN104224994B (zh) * | 2014-09-05 | 2016-05-04 | 陆江涛 | 一种祛风除湿的中药组合物及其制备方法 |
| CN105194469A (zh) * | 2015-11-11 | 2015-12-30 | 尹柱良 | 一种治疗银屑病的中药口服液及制备方法 |
| CN106215047A (zh) * | 2016-08-18 | 2016-12-14 | 初立国 | 一种治疗牛皮癣皮炎湿疹的药物及其制备方法 |
| JP2023503844A (ja) * | 2019-11-19 | 2023-02-01 | 天士力医薬集団股分有限公司 | 乾癬を治療する漢方薬組成物、その製造方法及び使用 |
| JP7547479B2 (ja) | 2019-11-19 | 2024-09-09 | 天士力医薬集団股分有限公司 | 乾癬を治療する漢方薬組成物、その製造方法及び使用 |
| CN113521141A (zh) * | 2020-04-17 | 2021-10-22 | 菏泽市牡丹区令中劳务有限公司 | 一种治疗牛皮癣用涂抹药膏 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103417879B (zh) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101934025B (zh) | 一种用于清热解毒的中药 | |
| CN101433654B (zh) | 一种治疗妇女慢性盆腔炎的中药制剂及其制备方法 | |
| CN103417879B (zh) | 一种治疗牛皮癣的药物 | |
| CN102462827A (zh) | 治疗波尔山羊产后乳房炎中药散剂配方 | |
| CN103169883B (zh) | 一种治疗小儿黄疸的中药 | |
| CN103638231B (zh) | 一种治疗荨麻疹的药物及其制备方法 | |
| CN101653540B (zh) | 一种治疗脓疱型牛皮癣的中药组合物 | |
| CN103041241B (zh) | 复方消银愈疕汤剂 | |
| CN110559374A (zh) | 一种具有抗hpv感染的药物及其制备方法 | |
| CN103908600A (zh) | 治疗类风湿性关节炎湿热痹阻证的外用药物、制备方法及给药方式 | |
| CN103301373B (zh) | 一种治疗产后会阴粘膜病变的药物组合物 | |
| CN115337379A (zh) | 一种治疗乳腺疾病的外用药物组合物及制备方法 | |
| CN101716317A (zh) | 一种内服外敷治疗类风湿性关节炎的中药组合物 | |
| CN102283991A (zh) | 一种治疗急性泌尿系统感染的药物及其制备方法 | |
| CN1241596C (zh) | 治疗膀胱炎的口服中药制剂 | |
| CN102205067B (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
| CN105770400A (zh) | 一种治疗产褥感染的中药组合物 | |
| CN103908603A (zh) | 一种治疗痛风的中药组合物及其制备方法 | |
| CN104324185A (zh) | 一种治疗白带过多的中药组合物及其制备方法 | |
| CN105031310A (zh) | 一种治疗风寒湿痹的药物及其制备方法 | |
| CN103301374B (zh) | 一种治疗产后非特异性阴道炎的药物组合物 | |
| CN103638448B (zh) | 一种治疗风湿性关节炎的药物及其制备方法 | |
| CN102552824B (zh) | 用于治疗银屑病的中成药 | |
| CN1216630C (zh) | 一种治疗阴道炎的外用药 | |
| CN106344838A (zh) | 一种治疗口腔溃疡的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150930 Termination date: 20190821 |